Gamze Gököz Doğu

11PUBLICATIONS
116CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 26, 2026
Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study.

|Feb 27, 2026
Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis.

Baris Koksal, Hasan Cagri Yildirim, Deniz Can Guven

|Feb 13, 2026
Prognostic Value of Systemic Inflammatory Markers in Locally Advanced or Metastatic Melanoma: A Real-World Analysis.

Burçin Çakan Demirel, Semra Taş, Taliha Güçlü Kantar

|Dec 30, 2025
Real-World Outcomes of Treatment Approaches and the Impact of Systemic Inflammation Markers on Survival in Patients with Locally Advanced and Metastatic Laryngeal Cancer.

Burçin Çakan Demirel, Semra Taş, Taliha Güçlü Kantar

|Dec 19, 2025
The efficacy of targeted therapies in metastatic squamous cell carcinoma of the lung: a Turkish Oncology Group multicentre study.

Bilgeşah Kılıçtaş, Murat Araz, Ahmet Oruç

|Nov 27, 2025
Lymphocyte-Associated Inflammation Markers Predict Bleomycin-Induced Pulmonary Toxicity in Testicular Cancer.

Melek Özdemir, Gamze Gököz Doğu, Burcu Yapar Taşköylü

Pageof 2

Frequent Collaborators

5 joint publications

Atike Gökçen Demiray

5 joint publications

Serkan Değirmencioğlu

5 joint publications

Melek Özdemir

4 joint publications

Arzu Yaren